Volumetry of the Olfactory‐Related Structure as a New Biomarker of Individuals at Risk of Alzheimer Disease? Results From the CIMA‐Q Cohort

Hippocampal and entorhinal atrophies are used as gold‐standard biomarkers of the prodromal stage of Alzheimer's disease (AD). These atrophies are related to episodic memory deficits found in individuals with mild cognitive impairment (MCI). Olfactory deficits have been identified as clinical biomarkers of AD and found in individuals with MCI. Olfactory‐related structures such as the primary olfactory cortex (POC) were found to be atrophied in patients with AD. The aim of this study was to evaluate if the atrophy of hippocampal and entorhinal regions in individuals with MCI was accompanied with the atrophy of the POC regions.